Literature DB >> 33638026

Endoplasmic reticulum stress and autophagy are involved in adipocyte-induced fibrosis in hepatic stellate cells.

Yingjuan Liu1,2, Xiaolin Wu1, Yue Wang1, Yunliang Guo3,4.   

Abstract

Liver fibrosis, with the characterization of progressive accumulation of extracellular matrix (ECM), is the common pathologic feature in the process of chronic liver disease. Hepatic stellate cells (HSCs) which are activated and differentiate into proliferative and contractile myofibroblasts are recognized as the main drivers of fibrosis. Obesity-related adipocytokine dysregulation is known to accelerate liver fibrosis progression, but the direct fibrogenic effect of mature adipocytes on HSCs has been rarely reported. Therefore, the purpose of this study was to explore the fibrogenic effect of adipocyte 3T3-L1 cells on hepatic stellate LX-2 cells. The results showed that incubating LX-2 cells with the supernatant of 3T3-L1 adipocytes triggered the expression of ECM related proteins, such as α-smooth muscle actin (α-SMA), type I collagen (CO-I), and activated TGF β/Smad2/3 signaling pathway in LX-2 cells. In addition, 3T3-L1 cells inhibited insulin sensitivity, activated endoplasmic reticulum stress and autophagy to promote the development of fibrosis. These results supported the notion that mature adipocytes can directly activate hepatic stellate cells, and the establishment of an in vitro model of adipocytes on HSCs provides an insight into screening of drugs for liver diseases, such as nonalcoholic fatty liver disease.

Entities:  

Keywords:  3T3-L1 cells; Autophagy; Endoplasmic reticulum stress; Fibrosis; LX-2 cells

Mesh:

Year:  2021        PMID: 33638026     DOI: 10.1007/s11010-020-03990-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  32 in total

1.  Leptin promotes methionine adenosyltransferase 2A expression in hepatic stellate cells by the downregulation of E2F-4 via the β-catenin pathway.

Authors:  Fangyun Cheng; Shengyan Su; Xiaofei Zhu; Xin Jia; Haimeng Tian; Xuguang Zhai; Wei Guan; Yajun Zhou
Journal:  FASEB J       Date:  2020-02-28       Impact factor: 5.191

2.  Ursodeoxycholic acid alleviates experimental liver fibrosis involving inhibition of autophagy.

Authors:  Hui-Lan Ye; Ji-Wang Zhang; Xing-Zhou Chen; Peng-Bo Wu; Li Chen; Guo Zhang
Journal:  Life Sci       Date:  2019-12-13       Impact factor: 5.037

3.  EID1 suppresses lipid accumulation by inhibiting the expression of GPDH in 3T3-L1 preadipocytes.

Authors:  Tomohiko Sato; Diana Vargas; Kakushin Miyazaki; Kaoru Uchida; Winda Ariyani; Mitsue Miyazaki; Junichi Okada; Fernando Lizcano; Noriyuki Koibuchi; Noriaki Shimokawa
Journal:  J Cell Physiol       Date:  2020-02-13       Impact factor: 6.384

Review 4.  Adipose Tissue-Liver Cross Talk in the Control of Whole-Body Metabolism: Implications in Nonalcoholic Fatty Liver Disease.

Authors:  Vian Azzu; Michele Vacca; Samuel Virtue; Michael Allison; Antonio Vidal-Puig
Journal:  Gastroenterology       Date:  2020-02-13       Impact factor: 22.682

5.  Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese.

Authors:  G J Ooi; S Mgaieth; G D Eslick; P R Burton; W W Kemp; S K Roberts; W A Brown
Journal:  Obes Rev       Date:  2017-11-09       Impact factor: 9.213

Review 6.  Does adipose tissue inflammation drive the development of non-alcoholic fatty liver disease in obesity?

Authors:  Adryana Cordeiro; Raquel Costa; Nelson Andrade; Cláudia Silva; Natalia Canabrava; Maria João Pena; Ilda Rodrigues; Sara Andrade; Andrea Ramalho
Journal:  Clin Res Hepatol Gastroenterol       Date:  2020-02-07       Impact factor: 2.947

7.  Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice.

Authors:  Oren Rom; Guan Xu; Yanhong Guo; Yunhao Zhu; Huilun Wang; Jifeng Zhang; Yanbo Fan; Wenying Liang; Haocheng Lu; Yuhao Liu; Michael Aviram; Zhipeng Liu; Seongho Kim; Wanqing Liu; Xueding Wang; Y Eugene Chen; Luis Villacorta
Journal:  EBioMedicine       Date:  2019-02-13       Impact factor: 8.143

8.  Isorhamnetin Inhibits Liver Fibrosis by Reducing Autophagy and Inhibiting Extracellular Matrix Formation via the TGF-β1/Smad3 and TGF-β1/p38 MAPK Pathways.

Authors:  Ning Liu; Jiao Feng; Xiya Lu; Zhilu Yao; Qing Liu; Yang Lv; Yuru Han; Jingfan Deng; Yingqun Zhou
Journal:  Mediators Inflamm       Date:  2019-07-31       Impact factor: 4.711

Review 9.  Metabolically Healthy Obesity.

Authors:  Matthias Blüher
Journal:  Endocr Rev       Date:  2020-05-01       Impact factor: 19.871

10.  Pharmacological inhibition of STAT3 pathway ameliorates acute liver injury in vivo via inactivation of inflammatory macrophages and hepatic stellate cells.

Authors:  Büsra Öztürk Akcora; Alexandros Vassilios Gabriël; Ana Ortiz-Perez; Ruchi Bansal
Journal:  FASEB Bioadv       Date:  2020-01-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.